About the Institute
The UCL Drug Discovery Institute is part of a wider Drug Discovery Alliance, funded by the charity Alzheimer’s Research UK and launched in 2015. Find out more about the Institute and how we operate.
What we do
The Alzheimer’s Research UK UCL Drug Discovery Institute is situated in the historic Cruciform building.
![Alzheimers-research-UK-Oxford-263[1]](https://ucl-ddi.alzheimersresearchuk.org/wp-content/uploads/bb-plugin/cache/Alzheimers-research-UK-Oxford-2631-scaled-panorama.jpg "Alzheimers-research-UK-Oxford-263[1]")
Leadership team
The Institute is made up of dedicated drug discovery teams led by a Chief Scientific Officer and three Lead Academic Scientists.
![expertise[1]](https://ucl-ddi.alzheimersresearchuk.org/wp-content/uploads/bb-plugin/cache/expertise1-panorama.jpg "expertise[1]")
Drug discovery team
Our Institute houses dedicated biology, chemistry, pharmacology and screening teams to evaluate promising new targets.
Contact us
We're open to discussions with individuals and organisations about potential projects and collaborations.